Shaker Investments’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-35,113
Closed -$3.36M 94
2020
Q4
$3.36M Sell
35,113
-10,311
-23% -$1.06M 1.69% 18
2020
Q3
$5.16M Sell
45,424
-660
-1% -$69.3K 2.64% 11
2020
Q2
$4.56M Buy
46,084
+13,668
+42% +$1.09M 2.59% 14
2020
Q1
$2.09M Buy
32,416
+325
+1% +$22.8K 1.79% 21
2019
Q4
$1.91M Buy
32,091
+4,893
+18% +$302K 1.14% 26
2019
Q3
$1.6M Buy
+27,198
New +$1.74M 1.05% 29
2017
Q3
Sell
-13,956
Closed -$112K 74
2017
Q2
$112K Sell
13,956
-1,838
-12% -$17K 0.08% 64
2017
Q1
$190K Hold
15,794
0.15% 62
2016
Q4
$340K Sell
15,794
-1,410
-8% -$54.2K 0.27% 58
2016
Q3
$1.32M Buy
+17,204
New +$1.25M 1.06% 27

Other funds holding TNDM

Shaker Investments's TNDM Position: Q1 2021 in Review

Shaker Investments sold out of Tandem Diabetes Care (TNDM) in Q1 2021, closing a stake of 35,113 shares — an estimated $3.36M sold.

Shaker Investments first reported a position in TNDM in Q3 2016 and held it in 10 quarters. The position peaked at $5.16M in Q3 2020. 290 funds tracked by Wall St. Rank hold TNDM as of Q1 2021.

  • Shaker Investments reported no remaining Tandem Diabetes Care position as of Q1 2021 after selling out during the quarter.
  • Shaker Investments sold 35,113 Tandem Diabetes Care shares in Q1 2021, an estimated $3.36M.
  • Shaker Investments first reported a position in Tandem Diabetes Care in Q3 2016 and held it in 10 quarters.
  • Shaker Investments's Tandem Diabetes Care position peaked at $5.16M in Q3 2020.
  • 290 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2021.

Based on Shaker Investments's 13F filing for Q1 2021, filed 5 May 2021.